Literature DB >> 2020017

Plasmid analysis of Mycobacterium avium-intracellulare (MAI) isolated in the United Kingdom from patients with and without AIDS.

T J Hellyer1, I N Brown, J W Dale, C S Easmon.   

Abstract

One hundred and forty-seven isolates (128 strains) of Mycobacterium avium-intracellulare (MAI) were screened by agarose gel electrophoresis for the presence of plasmids. Plasmids were characterised according to size and by Southern hybridisation analysis of intact and restriction endonuclease-digested DNA. Two cloned MAI plasmids, pLR7 and pLR20, were used as probes. There was no significant difference in the rate of plasmid carriage in MAI strains isolated from patients with the acquired immuno-deficiency syndrome (AIDS) and from non-AIDS patients in the UK, but a higher rate of plasmid carriage was observed in a panel of American strains from AIDS patients. Plasmids were grouped into two broad categories: small (mostly 14-30 kb) and large (greater than 150 kb). Southern blot analysis identified two distinct groups of small plasmids, the majority of which showed homology with pLR7. Plasmids from this group were significantly more common in strains of serotypes 4 and 8 which are particularly associated with AIDS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020017     DOI: 10.1099/00222615-34-4-225

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Characterization of isolates of Mycobacterium avium serotypes 4 and 8 from patients with AIDS by multilocus enzyme electrophoresis.

Authors:  M A Yakrus; M W Reeves; S B Hunter
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.

Authors:  M Picardeau; A Varnerot; T Lecompte; F Brel; T May; V Vincent
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Observed differences in virulence-associated phenotypes between a human clinical isolate and a veterinary isolate of Mycobacterium avium.

Authors:  K A Birkness; W E Swords; P H Huang; E H White; C S Dezzutti; R B Lal; F D Quinn
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Isolation by genetic labeling of a new mycobacterial plasmid, pJAZ38, from Mycobacterium fortuitum.

Authors:  J A Gavigan; J A Aínsa; E Pérez; I Otal; C Martín
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

5.  Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium.

Authors:  R C Cooksey; G P Morlock; M Beggs; J T Crawford
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

6.  Cell culture contamination by mycobacteria.

Authors:  G C Buehring; M Valesco; C Y Pan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

7.  Tetracycline resistance determinants in Mycobacterium and Streptomyces species.

Authors:  Y Pang; B A Brown; V A Steingrube; R J Wallace; M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

8.  Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection.

Authors:  Sasha J Rose; Luiz E Bermudez
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

Review 9.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Isolation and sequencing of the replication region of Mycobacterium avium plasmid pLR7.

Authors:  M L Beggs; J T Crawford; K D Eisenach
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.